Searched for
MAHAMAYA LIFESCIENCES SHARE LISTING
6 IPOs open for subscription with GMPs up to 28%. Check all detailsThe fresh offerings come amid mixed investor interest in the SME segment, although listing performance has remained muted in recent weeks, ...- Aastha Spintex IPO Day 2: GMP signals 4% listing gain; subscription nears full. Should you apply?Aastha Spintex's Rs 170 crore IPO entered Day 2 with a 4% grey market premium (GMP), indicating a potential listing around Rs 141 versus th...
- Bitcoin miner and AI firm Ionic Digital files for Nasdaq direct listingThe company was formed in January 2024 to acquire the cryptocurrency mining assets of Celsius Mining, a subsidiary of Celsius, which recei...
- Chinese tech manufacturers rush to list in Hong Kong, seeking nearly $6 billionThe biggest of the five offerings is Shenzhen-listed Apple supplier Luxshare Precision Industry, looking to raise up to HK$24.27 billion ...
- CSM Technologies IPO fully subscribed on final day; GMP hints at 4% listing gain. Should you subscribe?CSM Technologies' IPO successfully crossed the finish line, fully subscribed on its final day, driven by strong retail investor interest. T...
- Anubhav Plast shares list flat at IPO price of Rs 80 on BSE SME platformAnubhav Plast shares debuted at their IPO price of Rs 80 on the BSE SME platform, mirroring grey market expectations. The company's Rs 80 c...
- Turtlemint Fintech shares list at 11% discount to IPO price on NSE, BSETurtlemint Fintech Solutions experienced a subdued market debut, with shares listing at a discount to their IPO price on both NSE and BSE. ...
- IPO-bound NSE set to be the change in exchange gameIndia's sole listed stock exchange, BSE, faces a significant shift as rival NSE files for its own listing. NSE, dominating market share, is...
- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- Zydus, Sunshine to set up $20 million pharma JV in Sri LankaIndian pharmaceutical giant Zydus Lifesciences has partnered with Sri Lanka's Sunshine Healthcare Lanka to establish a new manufacturing fa...
- Tata Chemicals shares rise 4% on hopes of Tata Sons listing after RBI’s new normsTata Sons faces renewed scrutiny after RBI tightened rules for upper-layer NBFCs, reinforcing pressure for mandatory listings above Rs 1 la...
- Avience Biomedicals shares make blockbuster debut, list at 90% premium on NSE SMEAvience Biomedicals made a spectacular debut on the NSE SME platform, with its shares rocketing 90% on listing day. The Rs 30.24 crore IPO,...
- SK Hynix surges 12% as US listing plan boosts valuation hopesSK Hynix shares surged as much as 12% after the memory chipmaker unveiled plans for a $29 billion US listing, boosting hopes of higher valu...
- Leapfrog Engineering shares list at 4.3% discount from IPO price on BSE SMELeapfrog Engineering Services experienced a subdued market entry, with its shares listing at a 4.3% discount to the IPO price on the BSE SM...
- Liotech Industries shares list at 20% discount from IPO price on BSE SME platformThe Rs 36.02-crore IPO received a subdued response from investors, with the issue being subscribed 1.91 times during the three-day bidding ...
- Diksha Polymers shares list at 2% premium to IPO price on BSE SME platformDiksha Polymers debuted on the BSE SME platform at a slight premium, opening at Rs 114.50 against its IPO price of Rs 112. The Rs 17.9-cror...
- Clay Craft India shares to list today. Check GMP ahead of debutThe Rs 110.11-crore NSE SME IPO was subscribed 103.06 times during the three-day bidding period, led by strong demand from non-institutiona...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
- Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 millionZydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...
- Zydus Lifesciences completes acquisition of AssertioThe company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...
Load More
